The opinion in support of the decision being entered today was not written
for publication and is not binding precedent of the Board.
UNITED STATES PATENT AND TRADEMARK OFFICE
__________
BEFORE THE BOARD OF PATENT APPEALS
AND INTERFERENCES
__________
Ex parte SUZANNE DE LA MONTE and JACK R. WANDS
__________
Appeal No. 2006-02751
Application No. 09/964,667
__________
HEARD: March 9, 2006
__________
Before SCHEINER, GRIMES and GREEN, Administrative Patent Judges.
SCHEINER, Administrative Patent Judge.
DECISION ON APPEAL
This appeal involves a method of treating neuroectodermal tumors,
malignant astrocytomas, or glioblastomas, by administering an antisense
oligonucleotide or a ribozyme complementary to AD7c-NTP, a neural thread
protein expressed in neuronal cells and over-expressed in the brains of
Alzheimer’s disease patients. The examiner has rejected the claims as lacking
enablement. We have jurisdiction under 35 U.S.C. § 134. We will affirm this
rejection.
1 This appeal is related to an appeal in application serial no. 09/964,412 (appeal no. 2006-0299).
We have considered the two appeals together.
Page: 1 2 3 4 5 6 7 8 9 10 11 Next
Last modified: November 3, 2007